Following a successful pilot EQA scheme, RfB is expanding its external quality assurance portfolio and will in future offer the EQA scheme mild traumatic brain injury (mTBI) in serum twice a year.
Analytes of the EQA scheme:
- GFAP (glial fibrillary acidic protein)
- UCH-L1 (ubiquitin C-terminal hydrolase L1)
- Test strips
Registration is via your participant account at www.rfb.bio.
Remaining dates for 2026:
- Application deadline: 10.08.2026
- Dispatch: 08.09.2026
- EQA scheme period from: 14.09.2026
- EQA scheme period until: 26.09.2026
We look forward to your participation!
Your RfB team
